Literature DB >> 24801902

Activation of the ubiquitin-proteasome system against arsenic trioxide cardiotoxicity involves ubiquitin ligase Parkin for mitochondrial homeostasis.

Mayumi Watanabe1, Takeshi Funakoshi1, Kana Unuma1, Toshihiko Aki2, Koichi Uemura1.   

Abstract

Parkin is an E3 ubiquitin ligase involved in the elimination of damaged mitochondria. Ubiquitination of mitochondrial substrates by Parkin results in proteasomal as well as lysosomal degradation of mitochondria, the latter of which is executed by the autophagy machinery and is called as mitophagy (mitochondrial autophagy). The aim of this study is to examine the possible role of Parkin against cardiotoxicity elicited by arsenic trioxide (ATO) exposure in HL-1 mouse atrial cardiomyocytes. HL-1 cells were administered 1-10μM ATO for up to 24h, and the involvements of apoptosis, and the ubiquitin-proteasome and autophagy-lysosome systems (UPS and ALS) were examined. ATO dose-dependently reduced mitochondrial membrane potentials (ΔΨm) in HL-1 cells, indicating that ATO works as a mitochondrial toxin in these cells. Apoptosis was evident in cells exposed to more than 6μM ATO for 24h. Levels of Parkin in mitochondria-rich fractions were increased, suggesting the recruitment of Parkin to mitochondria. Ubiquitination of the voltage-dependent anion channel1 (VDAC1), a substrate of Parkin, was also proved by immunoprecipitation. Accumulation of ubiquitinated proteins including both K48- and K63-lineages was observed in HL-1 cells after ATO exposure, implying an increased demand for proteasomal as well as lysosomal degradation of cellular proteins. Although UPS was activated by ATO as proved by increased proteasomal activity, only slight activation of the ALS marker LC3 was observed, suggesting differential reactions of UPS and ALS to ATO toxicity. The abrogation of UPS by the proteasome inhibitor bortezomib significantly sensitized HL-1 cells to ATO toxicity, showing the contribution of UPS to the maintenance of cellular homeostasis during ATO exposure. Taken together, our results reveal the activation of Parkin as well as UPS during ATO exposure in HL-1 cardiomyocytes, which contributes to the maintenance of mitochondrial as well as cellular homeostasis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arsenic trioxide; Cardiomyocyte; HL-1; Mitophagy; Parkin; Ubiquitin–proteasome system

Mesh:

Substances:

Year:  2014        PMID: 24801902     DOI: 10.1016/j.tox.2014.04.008

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  11 in total

Review 1.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

2.  Monomethylarsonous acid, but not inorganic arsenic, is a mitochondria-specific toxicant in vascular smooth muscle cells.

Authors:  Clare Pace; Tania Das Banerjee; Barrett Welch; Roxana Khalili; Ruben K Dagda; Jeff Angermann
Journal:  Toxicol In Vitro       Date:  2016-06-17       Impact factor: 3.500

Review 3.  Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.

Authors:  Tarsheen K Sethi; Basak Basdag; Nirmanmoh Bhatia; Javid Moslehi; Nishitha M Reddy
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

4.  A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway.

Authors:  Yinping Zhao; Guangchao Zang; Tieying Yin; Xiaoyi Ma; Lifeng Zhou; Lingjuan Wu; Richard Daniel; Yunbing Wang; Juhui Qiu; Guixue Wang
Journal:  Bioact Mater       Date:  2020-09-04

5.  Parkin, as a Regulator, Participates in Arsenic Trioxide-Triggered Mitophagy in HeLa Cells.

Authors:  Zhewen Zhang; Juan Yi; Bei Xie; Jing Chen; Xueyan Zhang; Li Wang; Jingyu Wang; Jinxia Hou; Hulai Wei
Journal:  Curr Issues Mol Biol       Date:  2022-06-20       Impact factor: 2.976

Review 6.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 7.  Arsenic co-carcinogenesis: Inhibition of DNA repair and interaction with zinc finger proteins.

Authors:  Xixi Zhou; Rachel M Speer; Lindsay Volk; Laurie G Hudson; Ke Jian Liu
Journal:  Semin Cancer Biol       Date:  2021-05-10       Impact factor: 15.707

Review 8.  Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica-Induced Cardiotoxicity.

Authors:  Jie Zhou; Fu Peng; Xiaoyu Cao; Xiaofang Xie; Dayi Chen; Lian Yang; Chaolong Rao; Cheng Peng; Xiaoqi Pan
Journal:  Front Pharmacol       Date:  2021-03-30       Impact factor: 5.810

Review 9.  Mitochondrial Quality Control in Cardiomyocytes: A Critical Role in the Progression of Cardiovascular Diseases.

Authors:  Hualin Fan; Zhengjie He; Haofeng Huang; Haixia Zhuang; Hao Liu; Xiao Liu; Sijun Yang; Pengcheng He; Huan Yang; Du Feng
Journal:  Front Physiol       Date:  2020-03-27       Impact factor: 4.566

10.  Ginsenoside Rh2 inhibits HeLa cell energy metabolism and induces apoptosis by upregulating voltage‑dependent anion channel 1.

Authors:  Ying Liu; Jiawen Wang; Juhui Qiao; Shichao Liu; Siming Wang; Daqing Zhao; Xueyuan Bai; Meichen Liu
Journal:  Int J Mol Med       Date:  2020-09-14       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.